CHARLES RIVER LABORATORIES INTERNATIONAL, INC. ·
CRL 8-K 2026-09-24
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) 8-K dated 2026-09-24 — accession 0001100682-26-000142.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) is a diagnostics & research company listed on US.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. filed a 8-K on 2026-09-24. Accession 0001100682-26-000142.
This 8-K covers: Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported CRL revenue for 2025-12-27 was $4.02B. Net income was -$144.3M. Revenue was down 0.9% from 2024-12-28 to 2025-12-27. CRL currently screens at market cap $7.78B.
Not investment advice. The CRL SEC hub lists recent forms. The stock page is the research view.